Care at the End of Life
Reference27 articles.
1. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels
2. Dickenson DL. Are medical ethicists out of touch? 23. Lorenz K, Lynn J. Moral and practical challenges of Practitioner attitude in the US and UK towards physician-assisted suicide. JAMA 2003; 289:2282. decisions at the end of life. JMed Ethics 2000; 26: 24. Institute of Medicine. Approaching Death: Improving 254-260. Care at the End of Life. Washington, DC: National
3. Schneiderman LJ, Gilmer T, Teetzel HD, Dugan DO, Academy Press, 1997:14-49. Blustein J, Cranford R, Briggs KB, Komatsu GI, 25. Covinsky KE, Goldman L, Cook EF, The impact Goodman-Crews P, Cohn F, Young EWD. Effect of of serious illness on patients' families. JAMA 1994; ethics consultations on nonbeneficial life-sustaining 272:1839-1844. treatments in the intensive care setting: a randomized 26. Tang ST. When Death Is Imminent: Where Terminally controlled trial. JAMA 2003; 290:1166-1172. Ill Patients With Cancer Prefer to Die and Why?